Ledger.Open graph →

SEC Form D · filed December 5, 2017

Semma Therapeutics, Inc

Offering

$113.9M

Sold

$53.9M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

CAMBRIDGE, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Todd Foley · Cambridge, MAExec · Director Kevin Raidy · Cambridge, MADirector William Sahlman · Cambridge, MADirector Mitchell Finer · Cambridge, MADirector Kingsley Taft · Boston, MAExec Daniel Auerbach · Cambridge, MADirector Mark Fishman · Cambridge, MADirector Stephen Knight · Cambridge, MADirector Donna Garr · PHOENIX, AZDirector Mark E. Sofge · Atlanta, GADirector Dominick J. D'Eramo · WILMINGTON, DEDirector Amarnath Thombre · PHOENIX, AZExec J. A. Gonzalez · Houston, TXExec · Director Mark Galvin · Portsmouth, NHDirector Sandeep Wadhwa · PHOENIX, AZDirector Paul A. Burke · New York, NYDirector Elizabeth Stoner · Boston, MAExec Michael Episcope · chicago, ILExec · Director David Scherer · Chicago, ILDirector Shaun J. Mcnulty · Babraham, Cambridge, United KingdomDirector Derek Harp · Atlanta, GADirector Jon Strinden · Fargo, NDExec Rex Carlson · Fargo, NDDirector Andrew J. Harris · Washington, Washington, D.C.Director Erik Cornelissen · New York, NYDirector Elizabeth Stoner · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗